Etelcalcetide Versus Cinacalcet in Hemodialysis Patients in the United States: A Facility Calcimimetic Approach to Assess Real-World EffectivenessPlain-Language Summary

Etelcalcetide Versus Cinacalcet in Hemodialysis Patients in the United States: A Facility Calcimimetic Approach to Assess Real-World EffectivenessPlain-Language Summary

Rationale & Objective: Some US hemodialysis (HD) facilities switched from oral cinacalcet to intravenous etelcalcetide as the primary calcimimetic therapy to control parathyroid hormone (PTH) levels after the introduction of etelcalcetide in 2017. Although clinical trials have demonstrated t...

Full description

Bibliographic Details
Main Authors: Angelo Karaboyas, Daniel Muenz, Yunji Hwang, William Goodman, Sunfa Cheng, Pooja Desai, Kathleen M. Fox, Bruce M. Robinson, Ronald L. Pisoni
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Kidney Medicine
Subjects:
Calcimimetics
calcium
cinacalcet
etelcalcetide
phosphorus
PTH
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059522000899

Internet

http://www.sciencedirect.com/science/article/pii/S2590059522000899

Similar Items